Patent · US Active

1,2,4-oxadiazole derivatives as liver X receptor agonists

US11427586B2 · kind B2 · utility

0Cited by

0References

21Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Kelly D. BOSS · Cambridge, US
Yi Fan · Lawrence, US
Alec Nathanson Flyer · Cambridge, US
Declan HARDY · Cambridge, US
Zhihong HUANG · San Diego, US
Kathryn Taylor LINKENS · Austin, US
Jon Loren · San Diego, US
Fupeng Ma · Cambridge, US
Valentina Molteni · San Diego, US
Duncan Shaw · Chelmsford, GB
Jeffrey M. Smith · San Diego, US
Catherine Fooks SOLOVAY · Arlington, US

Key dates

Filing date	Nov 23, 2020
Grant date	Aug 30, 2022
Priority date	—
Expiry date	Nov 23, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Provided herein are compounds and pharmaceutical compositions useful for treating meibomian gland dysfunction (MGD), comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I) or a compound of Formula (I′), or pharmaceutical composition described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.